Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Integrated Solution for Diabetes Testing Is Efficient

By HospiMedica staff writers
Posted on 28 Aug 2007
Clinical laboratories will be provided with an integrated system for diabetes testing that automates sample processing, eliminates sample splitting, and improves operating efficiency while reducing costs and errors.

Sysmex America, Inc. More...
(Mundelein, IL, USA) and Bio-Rad Laboratories, Inc. (Hercules, CA, USA) have entered into a non-exclusive, multi-year distribution agreement to jointly market their complementary products with the aim of improving the efficiency and quality of diabetes testing. Sysmex will add Bio-Rad's diabetes testing method to the Sysmex HST-N automation line. Bio-Rad will supply their Variant II turbo link. Sysmex and Bio-Rad will work together to provide seamless service, training, installation, and customer support services.

Bio-Rad's hemoglobin A1c (A1C) blood test measures the amount of glucose attached to the hemoglobin in the red blood cell. This provides an estimate of how well blood glucose levels have been controlled during the previous three to four months. Bio-Rad's test is the industry's gold standard technology for determining whether a patient's diabetes is under control.

We are delighted to continue our long-standing history with Bio-Rad Laboratories, said John Kershaw, president, Sysmex America. The Bio-Rad Variant II turbo link is a perfect complement to the Sysmex HST-N hematology automation line. With the addition of A1c to our automation line, we can truly manage all the testing of the lavender top hematology sample tubes in the laboratory. Sysmex's lavender top management system provides hematology laboratories with the ability to conduct analysis of 90% of tests compatible with EDTA samples, such as complete blood count (CBC), Clostridium difficile, erythrocyte sedimentation rate (ESR), and A1c.

We are pleased to work with Sysmex in offering this integrated testing solution to clinical laboratories as it will enable them to provide superior diabetes testing services to doctors and their patients throughout the United States, said John Goetz, Bio-Rad vice president and group manager of clinical diagnostics.


Related Links:
Sysmex America
Bio-Rad Laboratories

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.